Bahattin Özkul
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bahattin Özkul has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Oytun Erbaş
Faculty of Medicine, Biruni Research Center (BAMER), Biruni University, Istanbul, Türkiye
7 shared publications - İbRahim Halil Sever
Department of Radiology, Demiroğlu Bilim University, Istanbul, Turkey
5 shared publications - Furkan Ertürk Urfalı
Department of Radiology, Bursa City Hospital, 16250 Bursa, Türkiye
4 shared publications - Yiğit Uyanıkgil
Department of Histology and Embryology Ege University, Faculty of Medicine Izmir Türkiye
4 shared publications - Mumin Alper Erdogan
Department of Physiology Izmir Katip Celebi University, Faculty of Medicine Izmir Türkiye
3 shared publications - Ozlem Ozkul
Department of Oncology, Istanbul Aydin University, Medicalpark Hospital, Akasya sok. No:4 Kucukcekmece/Istanbul, Turkey
3 shared publications
Latest Publications
- 15 December 2025
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 102 (3) , 232-245
Intranasal ketamine mitigates radiation-induced brain injury in a rabbit model by modulating ECM/PNN markers and neuroinflammation, with in vivo 1 H-MR spectroscopy readouts
Radiation-induced brain injury causes significant neurotoxicity and cognitive dysfunction in patients undergoing radiotherapy for brain tumors. This study aimed to evaluate the neuroprotective effects of intranasal ketamine on radiation-induced brain injury, specifically focusing on its modulation of perineuronal networks (PNNs), extracellular matrix components, and neuroinflammation. Eighteen male New Zealand White Rabbits were divided into three groups: normal controls, irradiation (IR) with saline (IR + saline), and IR with ketamine (IR + ketamine). Whole-brain IR (20 Gy) was applied to the IR groups, and ketamine (2 mg/kg/day) was administered intranasally for 15 days. Biochemical markers, including malondialdehyde (MDA), tumor necrosis factor-alpha (TNF-α), brain-derived neurotrophic factor (BDNF), ADAMTS4, and syndecan-1 levels, were measured. Histopathological analysis of hippocampal and cerebellar regions assessed neuronal survival and astrogliosis. Magnetic resonance spectroscopy (MRS) evaluated lactate and N-acetylaspartate (NAA) levels, reflecting metabolic and neuronal integrity. Ketamine administration significantly reduced oxidative stress (MDA) and inflammatory markers (TNF-α) while restoring BDNF levels compared to the IR + saline group. ADAMTS4 and syndecan-1 levels were reduced, changes consistent with PNN-associated extracellular matrix dynamics, but without direct confirmation by core PNN markers such as aggrecan or WFA staining. Histopathology showed increased neuronal survival and decreased reactive astrogliosis in ketamine-treated groups. 1H-MRS provided supporting evidence for metabolic changes (↓lactate, ↑NAA) consistent with improved mitochondrial function and neuronal integrity. Intranasal ketamine demonstrates significant neuroprotective effects in a radiation-induced brain injury model by reducing oxidative stress and inflammation, modulating extracellular matrix components, and preserving neuronal integrity. These findings highlight ketamine's potential as a therapeutic agent, although direct PNN markers and broader cytokine panels were not assessed. Overall, ketamine showed neuroprotective effects across biochemical, histological, and MRS-supported metabolic readouts.
- 15 December 2025
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 102 (3) , 232-245
Intranasal ketamine mitigates radiation-induced brain injury in a rabbit model by modulating ECM/PNN markers and neuroinflammation, with in vivo 1 H-MR spectroscopy readouts
Radiation-induced brain injury causes significant neurotoxicity and cognitive dysfunction in patients undergoing radiotherapy for brain tumors. This study aimed to evaluate the neuroprotective effects of intranasal ketamine on radiation-induced brain injury, specifically focusing on its modulation of perineuronal networks (PNNs), extracellular matrix components, and neuroinflammation. Eighteen male New Zealand White Rabbits were divided into three groups: normal controls, irradiation (IR) with saline (IR + saline), and IR with ketamine (IR + ketamine). Whole-brain IR (20 Gy) was applied to the IR groups, and ketamine (2 mg/kg/day) was administered intranasally for 15 days. Biochemical markers, including malondialdehyde (MDA), tumor necrosis factor-alpha (TNF-α), brain-derived neurotrophic factor (BDNF), ADAMTS4, and syndecan-1 levels, were measured. Histopathological analysis of hippocampal and cerebellar regions assessed neuronal survival and astrogliosis. Magnetic resonance spectroscopy (MRS) evaluated lactate and N-acetylaspartate (NAA) levels, reflecting metabolic and neuronal integrity. Ketamine administration significantly reduced oxidative stress (MDA) and inflammatory markers (TNF-α) while restoring BDNF levels compared to the IR + saline group. ADAMTS4 and syndecan-1 levels were reduced, changes consistent with PNN-associated extracellular matrix dynamics, but without direct confirmation by core PNN markers such as aggrecan or WFA staining. Histopathology showed increased neuronal survival and decreased reactive astrogliosis in ketamine-treated groups. 1H-MRS provided supporting evidence for metabolic changes (↓lactate, ↑NAA) consistent with improved mitochondrial function and neuronal integrity. Intranasal ketamine demonstrates significant neuroprotective effects in a radiation-induced brain injury model by reducing oxidative stress and inflammation, modulating extracellular matrix components, and preserving neuronal integrity. These findings highlight ketamine's potential as a therapeutic agent, although direct PNN markers and broader cytokine panels were not assessed. Overall, ketamine showed neuroprotective effects across biochemical, histological, and MRS-supported metabolic readouts.
- Open Access
- 19 October 2023
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 20, 1
Assessment of Apparent Diffusion Coefficient Parameters and Coefficient of Variance in Discrimination of Receptor Status and Molecular Subtypes of Breast Cancer
Objective: The objective of this study was to investigate the diagnostic power of apparent diffusion coefficient/coefficient of variance (ADCcV) as well as ADC parameters formed based on magnetic resonance images (MRI) in the distinction of molecular breast cancer subtypes. Methods: The study involved 205 patients who had breast cancer at stages 1-3. Estrogen receptor (EsR), progesterone receptor (PrR), human epidermal growth factor receptor 2 (Her2), and proliferation index (Ki-67) were histologically analyzed in the tumor. The correlations between the immunohistochemistry and intrinsic subtypes were analyzed using ADC and ADCcV. Results: The maximum whole tumor (WTu) ADC (p=0.004), minimum WTu ADC (p<0.001), and mean WTu ADC (p<0.001) values were significantly smaller in the EsR-positive tumors than those in the EsR-negative tumors. Compared to the PrR-negative tumors, the PrR-positive tumors showed significantly smaller maximum, minimum, and mean WTu ADC values (p=0.005, p=0.001, and p<0.001, respectively). In the comparisons of the molecular subtypes in terms of ADCcV, the p-values indicated statistically significant differences between the luminal A (lumA) group and the triple negative (TN) group, between the luminal B (lumB) group and the TN group, and between the Her2-enriched and TN groups (p<0.001, p=0.011, and p=0.004, respectively). Considering the luminal and non-luminal groups, while a significant difference was observed between the groups considering their minimum, maximum, and mean WTu ADC values, their ADCcV values were similar (p<0.001, p=0.004, and p<0.001, respectively). Conclusion: Using ADCcV in addition to ADC parameters increased the diagnostic power of diffusion weighted-MRI (DW-MRI) in the distinction of molecular subtypes of breast cancer.
- 19 October 2023
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 20, 1
Open AccessAssessment of Apparent Diffusion Coefficient Parameters and Coefficient of Variance in Discrimination of Receptor Status and Molecular Subtypes of Breast Cancer
Objective: The objective of this study was to investigate the diagnostic power of apparent diffusion coefficient/coefficient of variance (ADCcV) as well as ADC parameters formed based on magnetic resonance images (MRI) in the distinction of molecular breast cancer subtypes. Methods: The study involved 205 patients who had breast cancer at stages 1-3. Estrogen receptor (EsR), progesterone receptor (PrR), human epidermal growth factor receptor 2 (Her2), and proliferation index (Ki-67) were histologically analyzed in the tumor. The correlations between the immunohistochemistry and intrinsic subtypes were analyzed using ADC and ADCcV. Results: The maximum whole tumor (WTu) ADC (p=0.004), minimum WTu ADC (p<0.001), and mean WTu ADC (p<0.001) values were significantly smaller in the EsR-positive tumors than those in the EsR-negative tumors. Compared to the PrR-negative tumors, the PrR-positive tumors showed significantly smaller maximum, minimum, and mean WTu ADC values (p=0.005, p=0.001, and p<0.001, respectively). In the comparisons of the molecular subtypes in terms of ADCcV, the p-values indicated statistically significant differences between the luminal A (lumA) group and the triple negative (TN) group, between the luminal B (lumB) group and the TN group, and between the Her2-enriched and TN groups (p<0.001, p=0.011, and p=0.004, respectively). Considering the luminal and non-luminal groups, while a significant difference was observed between the groups considering their minimum, maximum, and mean WTu ADC values, their ADCcV values were similar (p<0.001, p=0.004, and p<0.001, respectively). Conclusion: Using ADCcV in addition to ADC parameters increased the diagnostic power of diffusion weighted-MRI (DW-MRI) in the distinction of molecular subtypes of breast cancer.
- Open Access
- 1 September 2023
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 66 (5) , 511-524
Reparative, Neuroprotective and Anti-neurodegenerative Effects of Granulocyte Colony Stimulating Factor in Radiation-Induced Brain Injury Model
Objective : This animal model aimed to compare the rat group that received brain irradiation and did not receive additional treatment (only saline) and the rat group that underwent brain irradiation and received Granulocyte colony stimulating factor (G-CSF) treatment. In addition, the effects of G-CSF on brain functions were examined by magnetic resonance (MR) imaging and histopathologically.Methods : This study used 24 female Wistar albino rats. Drug administration (saline or G-CSF) was started at the beginning of the study and continued for 15 days after whole-brain radiotherapy (WBRT). WBRT was given on day 7 of the start of the study. At the end of 15 days, the behavioral tests, including the three-chamber sociability test, open field test, and passive avoidance learning test, were done. After the behavioral test, the animals performed the MR spectroscopy procedure. At the end of the study, cervical dislocation was applied to all animals.Results : G-CSF treatment positively affected the results of the three-chamber sociability test, open-space test and passive avoidance learning test, cornu Ammonis (CA) 1, CA3, and Purkinje neuron counts, and the brain levels of brain-derived neurotrophic factor and postsynaptic density protein-95. However, G-CSF treatment reduced the glial fibrillary acidic protein immunostaining index and brain levels of malondialdehyde, tumor necrosis factor-alpha, nuclear factor kappa-B, and lactate. In addition, on MR spectroscopy, G-CSF had a reversible effect on brain lactate levels.Conclusion : In this first designed brain irradiation animal model, which evaluated G-CSF effects, we observed that G-CSF had reparative, neuroprotective and anti-neurodegenerative effects and had increased neurotrophic factor expression, neuronal counts, and morphology changes. In addition, G-CSF had a proven lactate-lowering effect in MR spectroscopy and brain materials.
- 1 September 2023
- Published by Korean Neurosurgical Society in Journal of Korean Neurosurgical Society
- Vol. 66 (5) , 511-524
Open AccessReparative, Neuroprotective and Anti-neurodegenerative Effects of Granulocyte Colony Stimulating Factor in Radiation-Induced Brain Injury Model
Objective : This animal model aimed to compare the rat group that received brain irradiation and did not receive additional treatment (only saline) and the rat group that underwent brain irradiation and received Granulocyte colony stimulating factor (G-CSF) treatment. In addition, the effects of G-CSF on brain functions were examined by magnetic resonance (MR) imaging and histopathologically.Methods : This study used 24 female Wistar albino rats. Drug administration (saline or G-CSF) was started at the beginning of the study and continued for 15 days after whole-brain radiotherapy (WBRT). WBRT was given on day 7 of the start of the study. At the end of 15 days, the behavioral tests, including the three-chamber sociability test, open field test, and passive avoidance learning test, were done. After the behavioral test, the animals performed the MR spectroscopy procedure. At the end of the study, cervical dislocation was applied to all animals.Results : G-CSF treatment positively affected the results of the three-chamber sociability test, open-space test and passive avoidance learning test, cornu Ammonis (CA) 1, CA3, and Purkinje neuron counts, and the brain levels of brain-derived neurotrophic factor and postsynaptic density protein-95. However, G-CSF treatment reduced the glial fibrillary acidic protein immunostaining index and brain levels of malondialdehyde, tumor necrosis factor-alpha, nuclear factor kappa-B, and lactate. In addition, on MR spectroscopy, G-CSF had a reversible effect on brain lactate levels.Conclusion : In this first designed brain irradiation animal model, which evaluated G-CSF effects, we observed that G-CSF had reparative, neuroprotective and anti-neurodegenerative effects and had increased neurotrophic factor expression, neuronal counts, and morphology changes. In addition, G-CSF had a proven lactate-lowering effect in MR spectroscopy and brain materials.
- Open Access
- 30 July 2023
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 6 (4) , 791-799
Lowering propionic acid levels by regulating gut microbiota with ursodeoxycholic acid appears to regress autism symptoms: an animal study
Aims: Patients with autism have altered gut microbiata, including higher frequency of bacteroidetes and clostridiales that produce of propionic acid (PPA) –a compound that is established as an autism-inducing agent. We hypothesized that lowering the PPA levels by regulating gut microbiata with ursodeoxycholic acid (UDCA) can regress the autism symptoms. The aim of this study is to examine the potential ameliorating effects of UDCA on a PPA-induced rat model of autism. Methods: Thirty male Wistar albino rats were divided into three groups: controls, PPA-induced (5 days of intraperitoneal 250 mg/kg/day dosage) autism model receiving oral saline, and PPA-induced autism model receiving oral UDCA (100 mg/kg/day). Oral treatments were applied for 15 days. At the end of the 15th day, all rats underwent behavioral tests and MR spectroscopy. At the end of the study, all animals were sacrificed and brain tissue / blood samples were collected for histopathological and biochemical analyses. Results: Sociability test, open field test and passive avoidance learning tests were impaired, similar to the autism behavioral pattern, in PPA recipients; however, results were closer to normal patterns in the PPA+UDCA group. Biochemically, MDA, TNF-alpha, IL-2, IL-17, NF-kB, lactate, NGF and NRF2 levels in brain tissues showed significant differences between controls and the PPA+Saline group, and between the PPA+Saline group and the PPA+UDCA group (p< 0.05, for all). Histopathology showed that PPA injection caused increased glial activity, neural body degeneration, decreased neural count and dysmorphic changes in hippocampal and cerebellar tissues (p<0.01, for all). UDCA treatment significantly ameliorated these changes. Conclusion: UDCA administration has ameliorating effects on PPA-induced autism-like behavioral, biochemical and histopathological changes in rats.
- 30 July 2023
- Published by Journal of Health Sciences and Medicine in Journal of Health Sciences and Medicine
- Vol. 6 (4) , 791-799
Open AccessLowering propionic acid levels by regulating gut microbiota with ursodeoxycholic acid appears to regress autism symptoms: an animal study
Aims: Patients with autism have altered gut microbiata, including higher frequency of bacteroidetes and clostridiales that produce of propionic acid (PPA) –a compound that is established as an autism-inducing agent. We hypothesized that lowering the PPA levels by regulating gut microbiata with ursodeoxycholic acid (UDCA) can regress the autism symptoms. The aim of this study is to examine the potential ameliorating effects of UDCA on a PPA-induced rat model of autism. Methods: Thirty male Wistar albino rats were divided into three groups: controls, PPA-induced (5 days of intraperitoneal 250 mg/kg/day dosage) autism model receiving oral saline, and PPA-induced autism model receiving oral UDCA (100 mg/kg/day). Oral treatments were applied for 15 days. At the end of the 15th day, all rats underwent behavioral tests and MR spectroscopy. At the end of the study, all animals were sacrificed and brain tissue / blood samples were collected for histopathological and biochemical analyses. Results: Sociability test, open field test and passive avoidance learning tests were impaired, similar to the autism behavioral pattern, in PPA recipients; however, results were closer to normal patterns in the PPA+UDCA group. Biochemically, MDA, TNF-alpha, IL-2, IL-17, NF-kB, lactate, NGF and NRF2 levels in brain tissues showed significant differences between controls and the PPA+Saline group, and between the PPA+Saline group and the PPA+UDCA group (p< 0.05, for all). Histopathology showed that PPA injection caused increased glial activity, neural body degeneration, decreased neural count and dysmorphic changes in hippocampal and cerebellar tissues (p<0.01, for all). UDCA treatment significantly ameliorated these changes. Conclusion: UDCA administration has ameliorating effects on PPA-induced autism-like behavioral, biochemical and histopathological changes in rats.
- 12 April 2023
- Published by Springer Nature in Journal of Neuroimmune Pharmacology
- Vol. 18 (1-2) , 9-23
Modafinil Improves Autism-like Behavior in Rats by Reducing Neuroinflammation
To evaluate the ameliorating effect of Modafinil on neuroinflammation, behavioral, and histopathological alterations in rats induced by propionic acid (PPA). Thirty male Wistar rats were used in the study, divided into 3 groups of ten subjects. One group served as a control, the subjects in the other two were given 250 mg/kg/day of PPA by intraperitoneal injection over the course of 5 days to induce autism. The experimental design was as follows: Group 1: Normal control (orally-fed control, n = 10); Group 2 (PPA + saline, n = 10): PPA and 1 ml/kg/day % 0.9 NaCl saline via oral gavage; Group 3 (PPA + Modafinil, n = 10) PPA and 30 mg/kg/day Modafinil (Modiodal tablets 100 mg, Cephalon) via oral gavage. All of the groups were investigated for behavioral, biochemical, and histological abnormality. Autism-like behaviors were reduced significantly in the rats treated with PPA. TNF-α, Nerve Growth Factor (NGF), IL-17, IL-2, and NF-KB levels as well as MDA levels and lactate were significantly higher in those treated with PPA compared to the control group. Using immunohistochemical methods, the number of neurons and GFAP immunoreactivity was significantly altered in PPA-treated rats compared to the control. Using Magnetic Resonance Spectroscopy (MRS), we found that lactate levels were significantly higher in the PPA-treated rats, while creatinine levels were significantly decreased. In the rats administered with Modafinil, behavior, neuroinflammation, and histopathological changes brought about by PPA were significantly reversed. Our results demonstrate the potential role of Modafinil in ameliorating PPA-induced neuroinflammation in rats. Graphical Abstract
- 12 April 2023
- Published by Springer Nature in Journal of Neuroimmune Pharmacology
- Vol. 18 (1-2) , 9-23
Modafinil Improves Autism-like Behavior in Rats by Reducing Neuroinflammation
To evaluate the ameliorating effect of Modafinil on neuroinflammation, behavioral, and histopathological alterations in rats induced by propionic acid (PPA). Thirty male Wistar rats were used in the study, divided into 3 groups of ten subjects. One group served as a control, the subjects in the other two were given 250 mg/kg/day of PPA by intraperitoneal injection over the course of 5 days to induce autism. The experimental design was as follows: Group 1: Normal control (orally-fed control, n = 10); Group 2 (PPA + saline, n = 10): PPA and 1 ml/kg/day % 0.9 NaCl saline via oral gavage; Group 3 (PPA + Modafinil, n = 10) PPA and 30 mg/kg/day Modafinil (Modiodal tablets 100 mg, Cephalon) via oral gavage. All of the groups were investigated for behavioral, biochemical, and histological abnormality. Autism-like behaviors were reduced significantly in the rats treated with PPA. TNF-α, Nerve Growth Factor (NGF), IL-17, IL-2, and NF-KB levels as well as MDA levels and lactate were significantly higher in those treated with PPA compared to the control group. Using immunohistochemical methods, the number of neurons and GFAP immunoreactivity was significantly altered in PPA-treated rats compared to the control. Using Magnetic Resonance Spectroscopy (MRS), we found that lactate levels were significantly higher in the PPA-treated rats, while creatinine levels were significantly decreased. In the rats administered with Modafinil, behavior, neuroinflammation, and histopathological changes brought about by PPA were significantly reversed. Our results demonstrate the potential role of Modafinil in ameliorating PPA-induced neuroinflammation in rats. Graphical Abstract
- Open Access
- 5 April 2023
- Published by Afyon Kocatepe University in Kocatepe Tıp Dergisi
- Vol. 24 (2) , 234-240
PREOPERATIVE EVALUATION OF LIVING DONOR KIDNEY VARIATIONS WITH MULTIDETECTOR COMPUTED TOMOGRAPHY AND COMPARISON OF RESULTS WITH INTRAOPERATIVE FINDINGS
AMAÇ: Bu çalışmayla, çok kesitli bilgisayarlı tomografi (ÇKBT) kullanarak canlı böbrek donörlerinde renal vasküler ve toplayıcı sistem varyasyonlarını değerlendirmek ve verileri retroperitonoskopik donör nefrektomisinde saptanan bulgular ile karşılaştırmak amaçlanmıştır. GEREÇ VE YÖNTEM: Çalışmaya, Ocak 2015 ile Ekim 2021 arasında merkezimizde retroperitonoskopik donör nefrektomisi olan ve operasyon öncesi uygun protokol ile gerçekleştirilmiş ÇKBT görüntülemesi mevcut olan 652 donör dahil edildi. Böbreklerdeki arteryel, venöz ve toplayıcı sistem varyasyonları ÇKBT incelemesiyle değerlendirilip not edilerek sonuçlar operasyon bulguları ile karşılaştırıldı. BULGULAR: Donörlerin %72,7’sine (474 kişi) sol nefrektomi, kalan 178 donöre (%27,3) ise sağ nefrektomi yapıldı. Nakledilen 652 böbreğin 99’unda (%15,1) çift arter, 11’inde (%1,6) üç arter ve 1’inde (%<1) dört arter mevcut iken; 14 (%2,1) böbrekte erken arteryel segmentasyon saptandı. Laparoskopik bulgulara göre 26 (%4) donör böbrekte çift renal ven, 3 (%0,4) böbrekte üç adet renal ven mevcut iken; 8 donörde yapısal venöz varyasyon ve 6 donörde toplayıcı sistem varyasyonu görüldü. Aksesuar arter varlığını saptamada, ÇKBT’nin duyarlılık, özgüllük, pozitif-negatif öngörü değeri ve doğruluk oranları sırasıyla %97,3; %98,5; %93,1; %99,4 ve %98,3 olarak bulundu. Arter sayılarını saptamadaki doğruluğu ise %98 olarak hesaplandı. Venlerdeki sayısal varyasyonu saptamada ÇKBT’nin duyarlılık, özgüllük, pozitif-negatif öngörü değeri ve doğruluk oranları sırasıyla %100; %99,8; %96,5; %100 ve %99,8 olarak bulundu. Ven sayılarını saptamadaki doğruluğu ise %99,8 olarak hesaplandı. Arteryel erken segmentasyon, geç venöz konfluens ve toplayıcı sistem varyasyonlarını tespit etmede ise %100 başarı sağlandı. SONUÇ: Doğru teknik ile gerçekleştirilen ÇKBT, canlı donör böbrek nakli için donör adaylarında renal vasküler ve toplayıcı sistem varyasyonlarının değerlendirilmesi için oldukça doğru bir yöntemdir.
- 5 April 2023
- Published by Afyon Kocatepe University in Kocatepe Tıp Dergisi
- Vol. 24 (2) , 234-240
Open AccessPREOPERATIVE EVALUATION OF LIVING DONOR KIDNEY VARIATIONS WITH MULTIDETECTOR COMPUTED TOMOGRAPHY AND COMPARISON OF RESULTS WITH INTRAOPERATIVE FINDINGS
AMAÇ: Bu çalışmayla, çok kesitli bilgisayarlı tomografi (ÇKBT) kullanarak canlı böbrek donörlerinde renal vasküler ve toplayıcı sistem varyasyonlarını değerlendirmek ve verileri retroperitonoskopik donör nefrektomisinde saptanan bulgular ile karşılaştırmak amaçlanmıştır. GEREÇ VE YÖNTEM: Çalışmaya, Ocak 2015 ile Ekim 2021 arasında merkezimizde retroperitonoskopik donör nefrektomisi olan ve operasyon öncesi uygun protokol ile gerçekleştirilmiş ÇKBT görüntülemesi mevcut olan 652 donör dahil edildi. Böbreklerdeki arteryel, venöz ve toplayıcı sistem varyasyonları ÇKBT incelemesiyle değerlendirilip not edilerek sonuçlar operasyon bulguları ile karşılaştırıldı. BULGULAR: Donörlerin %72,7’sine (474 kişi) sol nefrektomi, kalan 178 donöre (%27,3) ise sağ nefrektomi yapıldı. Nakledilen 652 böbreğin 99’unda (%15,1) çift arter, 11’inde (%1,6) üç arter ve 1’inde (%<1) dört arter mevcut iken; 14 (%2,1) böbrekte erken arteryel segmentasyon saptandı. Laparoskopik bulgulara göre 26 (%4) donör böbrekte çift renal ven, 3 (%0,4) böbrekte üç adet renal ven mevcut iken; 8 donörde yapısal venöz varyasyon ve 6 donörde toplayıcı sistem varyasyonu görüldü. Aksesuar arter varlığını saptamada, ÇKBT’nin duyarlılık, özgüllük, pozitif-negatif öngörü değeri ve doğruluk oranları sırasıyla %97,3; %98,5; %93,1; %99,4 ve %98,3 olarak bulundu. Arter sayılarını saptamadaki doğruluğu ise %98 olarak hesaplandı. Venlerdeki sayısal varyasyonu saptamada ÇKBT’nin duyarlılık, özgüllük, pozitif-negatif öngörü değeri ve doğruluk oranları sırasıyla %100; %99,8; %96,5; %100 ve %99,8 olarak bulundu. Ven sayılarını saptamadaki doğruluğu ise %99,8 olarak hesaplandı. Arteryel erken segmentasyon, geç venöz konfluens ve toplayıcı sistem varyasyonlarını tespit etmede ise %100 başarı sağlandı. SONUÇ: Doğru teknik ile gerçekleştirilen ÇKBT, canlı donör böbrek nakli için donör adaylarında renal vasküler ve toplayıcı sistem varyasyonlarının değerlendirilmesi için oldukça doğru bir yöntemdir.
- Open Access
- 1 January 2023
- Published by Kare Publishing in Turkish Journal of Trauma and Emergency Surgery
- Vol. 29 (9) , 963-971
Demonstration of ameliorating effect of papaverine in sepsis-induced acute lung injury on rat model through radiology and histology
Our target was to show the role of high mobility group box-1/receptor for (HMGB1/RAGE) interaction in feces intraperitoneal injection procedure (FIP)-induced acute lung injury (ALI) pathophysiology, to investigate the effect of papaverine on RAGE associated NF-κB pathway by determining the level of soluble RAGE (sRAGE) and HMGB1, and to support this hypothesis by evaluating inflammatory biochemical, oxidative stress markers, Hounsfield unit (HU) value in computed tomography (CT), and histopathological results. FIP was performed on 37 Wistar rats for creating a sepsis-induced ALI model. The animals were assigned into four groups as follows: Normal control (no treatment), placebo (FIP and saline), and receiving 20 mg/kg and 40 mg/kg per day papaverine. Twenty h after FIP, CT examination was performed for all animals, and HU value of the lung parenchyma was measured. The plasma levels of tumor necrosis factor (TNF)-α, HMGB1, sRAGE, C-reactive protein (CRP) and malondialdehyde (MDA), and lactic acid (LA) were determined and PaO2 and PaCO2 were measured from arterial blood sample. Lung damage was assessed by histopathological. TNF-, IL-6, CRP, HMGB1, MDA, LA levels, histopathologic scores, and HU values of CT were significantly increased and sRAGE levels were decreased in the saline-treated group against normal group (all P<0.05). Papaverine significantly reversed all results regardless of the dose (all P<0.05) and demonstrated inhibition of HMGB1/RAGE interaction through increasing sRAGE levels and suppresses the pro-inflammatory cytokines. We concluded that papaverine has ameliorating effects in rat model of ALI.
- 1 January 2023
- Published by Kare Publishing in Turkish Journal of Trauma and Emergency Surgery
- Vol. 29 (9) , 963-971
Open AccessDemonstration of ameliorating effect of papaverine in sepsis-induced acute lung injury on rat model through radiology and histology
Our target was to show the role of high mobility group box-1/receptor for (HMGB1/RAGE) interaction in feces intraperitoneal injection procedure (FIP)-induced acute lung injury (ALI) pathophysiology, to investigate the effect of papaverine on RAGE associated NF-κB pathway by determining the level of soluble RAGE (sRAGE) and HMGB1, and to support this hypothesis by evaluating inflammatory biochemical, oxidative stress markers, Hounsfield unit (HU) value in computed tomography (CT), and histopathological results. FIP was performed on 37 Wistar rats for creating a sepsis-induced ALI model. The animals were assigned into four groups as follows: Normal control (no treatment), placebo (FIP and saline), and receiving 20 mg/kg and 40 mg/kg per day papaverine. Twenty h after FIP, CT examination was performed for all animals, and HU value of the lung parenchyma was measured. The plasma levels of tumor necrosis factor (TNF)-α, HMGB1, sRAGE, C-reactive protein (CRP) and malondialdehyde (MDA), and lactic acid (LA) were determined and PaO2 and PaCO2 were measured from arterial blood sample. Lung damage was assessed by histopathological. TNF-, IL-6, CRP, HMGB1, MDA, LA levels, histopathologic scores, and HU values of CT were significantly increased and sRAGE levels were decreased in the saline-treated group against normal group (all P<0.05). Papaverine significantly reversed all results regardless of the dose (all P<0.05) and demonstrated inhibition of HMGB1/RAGE interaction through increasing sRAGE levels and suppresses the pro-inflammatory cytokines. We concluded that papaverine has ameliorating effects in rat model of ALI.
- 30 November 2022
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 51 (4) , 715-722
Indirect evaluation of amyloid deposition by ultrasonography and its relationship with MEFV gene mutation in FMF patients
Objective: The most significant complication in familial mediterranean fever (FMF) patients is dysfunction and organ failure developing depending on amyloid deposition in organs. The golden standard for showing amyloid deposition is the biopsy; however, tissue stiffness was examined by shear wave elastography as a non‐invasive method in a restricted number of studies conducted, and it is considered that amyloid deposition can be shown indirectly. In our study, we aimed to indirectly evaluate amyloid deposition in organs with Shear wave and Doppler ultrasonography and to reveal its relationship with MEFV gene mutation analysis.Method: 42 FMF patients with normal thyroid and renal function tests and 35 participants with no FMF symptoms were included in our study. FMF patients were grouped depending on their MEFV mutation analyses. Thyroid, salivary glands, and renal parenchymal tissue stiffness were evaluated by shear wave elastography. Thyroidal artery and both renal artery resistances were evaluated by Doppler ultrasonography.Results: Both parotis gland, thyroid and renal parenchymal stiffness and arterial vascular resistances in the patient group were found higher than the control group. A significant difference was not found in any parameters in classification based on gender. Tissue stiffness and vascular resistance values in the patient group with M694V homozygote mutation were found statistically significantly higher than the other mutation groups (p < 0.001).Conclusion: Our study shows that identifying genetic mutation type in FMF patients will help determine possibly amyloidosis risk. Imaging of tissue stiffness by shear wave elastography and evaluation of vascular resistance by Doppler can be useful for routine screening of those patients.
- 30 November 2022
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 51 (4) , 715-722
Indirect evaluation of amyloid deposition by ultrasonography and its relationship with MEFV gene mutation in FMF patients
Objective: The most significant complication in familial mediterranean fever (FMF) patients is dysfunction and organ failure developing depending on amyloid deposition in organs. The golden standard for showing amyloid deposition is the biopsy; however, tissue stiffness was examined by shear wave elastography as a non‐invasive method in a restricted number of studies conducted, and it is considered that amyloid deposition can be shown indirectly. In our study, we aimed to indirectly evaluate amyloid deposition in organs with Shear wave and Doppler ultrasonography and to reveal its relationship with MEFV gene mutation analysis.Method: 42 FMF patients with normal thyroid and renal function tests and 35 participants with no FMF symptoms were included in our study. FMF patients were grouped depending on their MEFV mutation analyses. Thyroid, salivary glands, and renal parenchymal tissue stiffness were evaluated by shear wave elastography. Thyroidal artery and both renal artery resistances were evaluated by Doppler ultrasonography.Results: Both parotis gland, thyroid and renal parenchymal stiffness and arterial vascular resistances in the patient group were found higher than the control group. A significant difference was not found in any parameters in classification based on gender. Tissue stiffness and vascular resistance values in the patient group with M694V homozygote mutation were found statistically significantly higher than the other mutation groups (p < 0.001).Conclusion: Our study shows that identifying genetic mutation type in FMF patients will help determine possibly amyloidosis risk. Imaging of tissue stiffness by shear wave elastography and evaluation of vascular resistance by Doppler can be useful for routine screening of those patients.
- 1 September 2022
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 18 (10) , 1079-1085
Predicting the Overall Survival in Patients with Advanced Pancreatic Cancer by Calculating L3 Skeletal Muscle Index Derived from CT
Background Pancreatic cancer is mostly diagnosed in advanced stages and treatment results are not satisfactory. L3 skeletal muscle index (SMI) has emerged as a prognostic factor in pancreatic cancer patients. We aimed to assess the association between sarcopenia and overall survival in patients with pancreatic cancer in this study. Methods Patients who admitted to Department of Oncology between March 2012 and December 2019 and diagnosed as pancreatic cancer were evaluated. A total of 115 patients who had computerized tomography images and laboratory parameters were included in this retrospective single center study. We defined sarcopenia as a SMI <43,56 cm²/m² for females and <56,44 cm²/m² for males using the receiver operating characteristics (ROC) curve in the study population. Univariate and multivariate analyses were performed by using Cox-regression modelling and survival curves were constructed by using Kaplan-Meier method. Results 70% of the patients were male and the mean age was 64.9±9.9 (mean SD). 70.6% of female patients and 67.9% of male patients were stage 4. The prevalence of sarcopenia in the whole patient group was 29.6%. By multivariate analysis, SMI (p=0.009) and advanced stage (p=0.003) were found as poor prognostic factor for overall survival (OS). The neutrophil to lymphocyte ratio (NLR) was statistically significant higher in sarcopenic patients than in non-sarcopenic patients (p=0.031). Conclusion In patients, who have sarcopenia at the time of diagnosis may be poorer overall survival of pancreas cancer and SMI may be considered as a potential prognostic factor.
- 1 September 2022
- Published by Bentham Science Publishers Ltd. in Current Medical Imaging
- Vol. 18 (10) , 1079-1085
Predicting the Overall Survival in Patients with Advanced Pancreatic Cancer by Calculating L3 Skeletal Muscle Index Derived from CT
Background Pancreatic cancer is mostly diagnosed in advanced stages and treatment results are not satisfactory. L3 skeletal muscle index (SMI) has emerged as a prognostic factor in pancreatic cancer patients. We aimed to assess the association between sarcopenia and overall survival in patients with pancreatic cancer in this study. Methods Patients who admitted to Department of Oncology between March 2012 and December 2019 and diagnosed as pancreatic cancer were evaluated. A total of 115 patients who had computerized tomography images and laboratory parameters were included in this retrospective single center study. We defined sarcopenia as a SMI <43,56 cm²/m² for females and <56,44 cm²/m² for males using the receiver operating characteristics (ROC) curve in the study population. Univariate and multivariate analyses were performed by using Cox-regression modelling and survival curves were constructed by using Kaplan-Meier method. Results 70% of the patients were male and the mean age was 64.9±9.9 (mean SD). 70.6% of female patients and 67.9% of male patients were stage 4. The prevalence of sarcopenia in the whole patient group was 29.6%. By multivariate analysis, SMI (p=0.009) and advanced stage (p=0.003) were found as poor prognostic factor for overall survival (OS). The neutrophil to lymphocyte ratio (NLR) was statistically significant higher in sarcopenic patients than in non-sarcopenic patients (p=0.031). Conclusion In patients, who have sarcopenia at the time of diagnosis may be poorer overall survival of pancreas cancer and SMI may be considered as a potential prognostic factor.
- 30 June 2022
- Published by Marmara University in Clinical and Experimental Health Sciences
- Vol. 12 (2) , 528-532
Quantitative Evaluation of Lung Parenchyma Changes after Treatment in COVID-19 Pneumonia with Volumetric Study in Computed Tomography
Objective COVID-19 pandemic, causing approximately 3 million deaths over worldwide, still continues. Effect of COVID-19 pneumonia after treatment on the lungs still not know. Although widely using computed tomography (CT) for diagnosing COVID-19 pneumonia, there is not enough study to determine damage of lung after treatment in COVID-19 pneumonia. In this study, our aim was to evaluate lung parenchyma changes in COVID-19 pneumonia after treatment with volumetric study, quantitatively. Methods 25 patients, who has CT at the time of diagnosis (CT1) and after 282 days (CT2), and positive polymerase chain reaction test, were included in this retrospective single center study. Total lung volüme (TLV) and emphysematous lung (ELV) volume of CT1 and CT2 were calculated automatically by using Myrian® XP-Lung and Percentage of emphysematous area (PEA) was calculated by dividing ELV by TLV. Differences between CT1 and CT2 in PEA and in TLV and ELV was determined by Wilcoxon and Paired sample t test, respectively. Results Although higher TLV was found in CT2 (4216,43 ± 1048,99 cm3) than CT1 (3943,22 ± 1177,16 cm3), there was no statistical significance difference (p=0.052) between CT1 and CT2. ELV was statistically (p=0.017) higher in CT2 (937,22 ± 486,89 cm3) than CT1 (716,26 ± 471,65 cm3). There was a strong indication that the medians were significantly different in PEA (p=0,009). Conclusions Our study showed that there were emphysematous changes in lung parenchyma after COVID-19 pneumonia with CT, quantitatively and in our knowledge, this is the first study that evaluating lung changes quantitative after COVID-19 pneumonia. .
- 30 June 2022
- Published by Marmara University in Clinical and Experimental Health Sciences
- Vol. 12 (2) , 528-532
Quantitative Evaluation of Lung Parenchyma Changes after Treatment in COVID-19 Pneumonia with Volumetric Study in Computed Tomography
Objective COVID-19 pandemic, causing approximately 3 million deaths over worldwide, still continues. Effect of COVID-19 pneumonia after treatment on the lungs still not know. Although widely using computed tomography (CT) for diagnosing COVID-19 pneumonia, there is not enough study to determine damage of lung after treatment in COVID-19 pneumonia. In this study, our aim was to evaluate lung parenchyma changes in COVID-19 pneumonia after treatment with volumetric study, quantitatively. Methods 25 patients, who has CT at the time of diagnosis (CT1) and after 282 days (CT2), and positive polymerase chain reaction test, were included in this retrospective single center study. Total lung volüme (TLV) and emphysematous lung (ELV) volume of CT1 and CT2 were calculated automatically by using Myrian® XP-Lung and Percentage of emphysematous area (PEA) was calculated by dividing ELV by TLV. Differences between CT1 and CT2 in PEA and in TLV and ELV was determined by Wilcoxon and Paired sample t test, respectively. Results Although higher TLV was found in CT2 (4216,43 ± 1048,99 cm3) than CT1 (3943,22 ± 1177,16 cm3), there was no statistical significance difference (p=0.052) between CT1 and CT2. ELV was statistically (p=0.017) higher in CT2 (937,22 ± 486,89 cm3) than CT1 (716,26 ± 471,65 cm3). There was a strong indication that the medians were significantly different in PEA (p=0,009). Conclusions Our study showed that there were emphysematous changes in lung parenchyma after COVID-19 pneumonia with CT, quantitatively and in our knowledge, this is the first study that evaluating lung changes quantitative after COVID-19 pneumonia. .